Recent molecular and therapeutic advances in B-cell non-Hodgkin lymphoma in children.

about

Inhibition of Hsp90 Suppresses PI3K/AKT/mTOR Signaling and Has Antitumor Activity in Burkitt Lymphoma.

P2860

Q50942188-FB20CEE8-6155-4691-8058-19FB4FB39E94

P2860

Recent molecular and therapeutic advances in B-cell non-Hodgkin lymphoma in children.

Item

http://www.wikidata.org/entity/Q38782141

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Recent molecular and therapeutic advances in B-cell non-Hodgkin lymphoma in children.

@en

type

Item

label

Recent molecular and therapeutic advances in B-cell non-Hodgkin lymphoma in children.

@en

prefLabel

Recent molecular and therapeutic advances in B-cell non-Hodgkin lymphoma in children.

@en

P1476

Recent molecular and therapeutic advances in B-cell non-Hodgkin lymphoma in children.

@en

P2093

Lisa Giulino-Roth

http://www.w3.org/2001/XMLSchema#string

Stanton Goldman

http://www.w3.org/2001/XMLSchema#string

P2860

A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma

Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing

Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma

Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma

A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.

Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin.

Lenalidomide combined with R-CHOP overcomes negative prognostic impact of non-germinal center B-cell phenotype in newly diagnosed diffuse large B-Cell lymphoma: a phase II study

Chimeric antigen receptor T cells for sustained remissions in leukemia

PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma

P304

531-544

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BJH.13969

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

173

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26996160

http://www.w3.org/2001/XMLSchema#string

Recent molecular and therapeutic advances in B-cell non-Hodgkin lymphoma in children.

about

P2860

P2860

Recent molecular and therapeutic advances in B-cell non-Hodgkin lymphoma in children.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698